文献速递泌尿男性生殖肿瘤

61岁局限期前列腺癌患者问:哪种放疗适合我?

A Younger Man With Localized Prostate Cancer Asks, "Which Type of Radiation Is Right for Me?".
PubMed 文献 · J Clin Oncol · 2018-05-02

本文以一例61岁、接受主动监测16个月后升级为II期前列腺癌(T1cN0M0,PSA 4.8 ng/mL,Grade Group II,3/12针阳性)的患者为引,呈现诊断与治疗决策挑战,并综述相关文献,汇总作者建议的管理策略,帮助读者将关键研究结果用于临床实践。

要点

  • 病例为61岁男性,主动监测后升级为II期前列腺癌,PSA 4.8 ng/mL,Grade Group II。
  • 文章以病例为线索,讨论局限期前列腺癌放疗选择相关的诊断与管理挑战。
  • 文章汇总作者基于文献回顾所建议的管理方法,供临床实践参考。

核心结论

  • 文章旨在帮助读者将关键研究结果应用于局限期前列腺癌患者的临床实践。

研究设计与样本

  • Oncology Grand Rounds系列文章,以病例展示引入,随后描述诊断与管理挑战并回顾相关文献。

主要发现

  • 患者61岁,最初为I期前列腺癌(T1cN0M0,PSA 4.5 ng/mL,Grade Group 1,1/12针阳性),主动监测16个月后活检升级为Grade Group II(最高Gleason 3+4),3/12针阳性(右中腺及右尖)。
  • 当前分期为T1cN0M0,PSA 4.8 ng/mL,多参数MRI示外周带不均匀、无优势病灶,前列腺体积28 mL。
  • 患者有高胆固醇血症并服用阿托伐他汀,父亲70余岁患前列腺癌、89岁死于其他原因。
  • 患者排尿频率2–3小时一次、夜尿0–1次,勃起功能无障碍。

临床怎么用

  • 文章通过病例与文献回顾,为局限期前列腺癌放疗方式的选择提供临床参考框架。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 61-year-old man presents with stage II prostate cancer after a period of active surveillance. Work-up reveals T1cN0M0 carcinoma, a prostate-specific antigen (PSA) level of 4.8 ng/mL, and Grade Group II (highest Gleason 3+4) in three cores of 12 taken, at the right mid-gland and right apex. The patient has been on active surveillance for the past 16 months. He was originally diagnosed after biopsy for an elevated PSA with stage I prostate cancer, T1cN0M0; PSA, 4.5 ng/mL; Grade Group 1 (Gleason 3+3) in one core of 12 taken, also at the right mid-gland. A multiparametric magnetic resonance imaging scan showed a heterogeneous peripheral zone without a dominant lesion and a calculated prostate volume of 28 mL. His medical history includes hypercholesterolemia, for which he takes atorvastatin. He is otherwise healthy and has no other significant medical or surgical history. His father had prostate cancer in his 70s and died of other causes at 89 years of age. The patient reports 2- to 3-hour urinary frequency and 0 to 1 nocturia, and has no difficulty obtaining or maintaining an erection. After meeting with his urologist, he sees a radiation oncologist.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Bekelman JE. A Younger Man With Localized Prostate Cancer Asks, "Which Type of Radiation Is Right for Me?". J Clin Oncol. 2018. PMID: 29718792. doi:10.1200/JCO.2018.77.7235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。